Yahoo Web Search

  1. Ad

    related to: daphne koller insitro 2
  2. AI-driven insights for drug development efficiency and success. Actionable insights to de-risk drug development with AI

Search results

  1. 5 days ago · AI & drug discovery: A biotech CEO, a scientist, and a venture capitalist separate hype from reality. By Casey Ross and Matthew Herper. Reprints. From left: Daphne Koller, CEO of Insitro, Vijay ...

  2. 2 days ago · When Insitro founder and CEO Daphne Koller, who co-founded an online education service and was chief computing officer at anti-aging drug developer Calico, reached out to Fox, the professor had ...

  3. People also ask

  4. May 1, 2024 · May 01, 2024. 5 mins. Daphne Koller. AI Magazine examines the life and legacy of Daphne Koller, as she continues the advancement of digital learning and utilising AI within biomedicine. More than 30 years ago, Daphne Koller was the first machine learning hire in Stanford University’s Computer Science department.

  5. May 15, 2024 · AI pioneer and insitro CEO Daphne Koller is betting it will—at the very least—supercharge the hunt for new drugs. She breaks down her strategy in this Institute Dialogue with Paul McCracken, CPP Investments’ Managing Director Growth Equity and Nadeem Janmohamad, Managing Director Active Equities North America.

  6. May 16, 2024 · 872 subscribers. Subscribed. 1. 30 views 1 day ago. Will artificial intelligence find the cure for what ails us? AI pioneer and insitro CEO Daphne Koller is betting it will—at the very...

  7. May 16, 2024 · As co-founder of Coursera, Daphne Koller transformed the landscape of online learning. With insitro, she’s aiming even higher, with a goal to disrupt longstanding approaches to drug development. She breaks down her strategy in this Institute Dialogue with Paul McCracken, CPP Investments’ Managing Director Growth Equity and Nadeem Janmohamad ...

  8. 3 days ago · On reimagining medicine Computer scientist and Coursera co-founder Daphne Koller explained how her latest company insitro is using machine learning and data to reimagine medicine and accelerate drug discovery.

  1. People also search for